期刊文献+

RhoC沉默抑制卵巢癌细胞的生长及转移 被引量:1

RhoC miRNA inhibits the movement and invasiveness of ovarian cancer SKOV3 cells
下载PDF
导出
摘要 目的:探讨RNA干扰技术沉默Ras homolgyC(RhoC)对卵巢癌细胞SKOV3细胞运动和侵袭力的影响。方法:利用Invitrogenis RNAi Designer软件设计并构建RhoC的干扰RNA(miRNA)载体,利用质脂体介导法将RhoC miRNA及非特异miRNA转染卵巢癌SKOV3细胞,经blasticdin进行稳定筛选出抗性克隆;将实验分为RhoC miRNA组(转染特异miRNA)、非特异miRNA组(转染非特异性miRNA)、空白对照组(不转染RhoC miRNA)。Western blot检测3组卵巢癌细胞中RhoC蛋白表达水平;同时检测对卵巢癌细胞体外运动及侵袭的抑制作用。结果:SKOV3细胞稳定转染后,转染特异性miRNA组RhoC蛋白表达量[0.1989(4257/21498)]与转染非特异miRNA组[2.142(38245/17855)]和空白对照组[2.604(48872/18768)]相比,差异均有统计学意义(P<0.01),而非特异性组与空白对照组之间差异无统计学意义(P>0.05);体外细胞运动实验表明,转染特异性miRNA组与转染非特异性miRNA组及空白对照组跨膜细胞数[分别为(52±3)个、(401±28)个及(432±28)个/高位镜(×200)]比较,差异均有统计学意义(P<0.01),而转染非特异性miRNA组与空白对照组之间差异无统计学意义(P>0.05)。重组细胞基底膜(Matrigel)侵袭实验显示,以上3组穿透基底膜细胞数[分别为(48±9)个、(386±26)个及(424±25)个/高位镜(×200)]比较,差异均有统计学意义(P<0.01),而后两组之间无统计学意义(P>0.05)。结论:抑制卵巢癌SKOV3细胞RhoC蛋白的表达对卵巢癌细胞的运动及侵袭有抑制作用,这可能为卵巢癌转移的基因治疗提供新的靶点。 Objective:To investigate the inhibitory effects of RNA interference (RNAi) targeting Ras homologyC(RhoC) on the invasion of ovary carcinoma cell lines SKOV3 in vitro. Methods: RhoC - micro interfering RNAs(miRNA) were designed and the related vectors were constructed by lnvitrogenis RNAi Designer. The vectors were transfected into human ovarian cancer cells SKOV3 through Lipofectamine. Blasticdin was used to select the hardiness single clonies after stable transfection of RhoC miRNA. Human ovarian cancer cells SKOV3 were cultured under being divided into 3 groups: PhoC miRNA group (transfected with RhoC miRNA), non-specific miRNA group(transfected with non-specific miRNA), and control group( without transfection). The protein expression of Phoc of 3 groups of cells were examined by Western blot, and the inhibitory effects of RhoC miRNA on the movement and invasiveness of ovarian cancer cells were detected by Transwell motility as- say and Matrigel invasion ashy. Results: After SKOV3 cells were stablely transfected, the protein expression of RhoC in RhoC miRNA group [0.198 9(4 257/21 498)1 had greater statistical significance (P 〈 0.01 ) compared with those of the non-specific miRNA group[2. 142(38 245/17 855)] and the control group[2. 604(48 872/18 768)]. It was showed hy the motility activity that the cells infiltrated into Basement Membrane on PhoC miRNA group (52 ± 3)had statistical siguificance ( P 〈 0.01 )compared with those of the non-specific miRNA group(401 ± 28)and the control group (432±28). By the invasion activity it was shown the cells were infiltrated into Basement Membrane in RhoC miRNA group (48 ± 9), which was statistically significant ( P 〈 0.01 ) compared with those of the non-specific miRNA group( 386 ± 26) and the control group (424 ± 25). Conclusion: The data indicate that the expressing inhibition of PhoC protein in ovarian cancer cells has supressing effects on the movement and invasiveness of ovarian cancer ceils. RhoC miRNA is possibly a potential target for gene therapy in blocking invasion and metastasis of human ovarian cancer.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第5期425-429,共5页 Chinese Journal of Immunology
基金 吉林省科技厅攻关项目资助课题(2006415-3)
关键词 卵巢肿瘤 RNA RHOC蛋白 侵袭 Ovarian neoplasms RNA RhoC protein Invasion
  • 相关文献

参考文献3

二级参考文献20

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:213
  • 2W.Michael Korn Division of Gastroenterology and Comprehensive Cancer Canter,University of California San Francisco,San Francisco,CA 94143-0128,USA.Moving toward an understanding of the metastatic process in hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(6):777-778. 被引量:13
  • 3韩志强,张阿丽,吴明富,刘玉兰,陈刚,李辅军,高庆蕾,廖国宁,卢运萍,王世宣,马丁.RhoA、RhoC及其效应分子ROCK-1的表达与卵巢癌细胞系恶性行为相关性的体外研究[J].中华肿瘤杂志,2004,26(7):385-388. 被引量:18
  • 4庄芸,胡华成.MMP-2、MMP-9及其抑制剂在肺癌中的表达与临床意义[J].江南大学学报(自然科学版),2005,4(3):324-327. 被引量:6
  • 5[2]Furuva M,Ishikura H,Nemori R,et al.Calssification of the active gelatinolytic sites in human ovarian neoplasms using in situzyrnography.[J].HumPathol,2001,32 (2):163-168.
  • 6[3]Giannelli G,Falk-Marzillier J,Schiraldi D,et al.Induction of cell migration by matrix metallop roteinase-2 cleavage of laminin-51[J].Science,1997,89 (8):1260-1263.
  • 7[4]Morris SW,Valentine MB,Kirstein MN,et al.Reassignment of the human ARH9.RAS-related.gene.to.ehromosomelp13-p21[J].Genomies,1993,15 (3):677-679.
  • 8[5]Lamper K,Machein U,Machein MR,et al.Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.[J].Am J Pathol,1998,153:429-432.
  • 9[6]Fridman R,Fuerst TR,Bird RE,et al.Domain structure of human 72-KDa,gelatinase/type Ⅳ collagenase[J].Biol Chem,1992,267:15398-15405.
  • 10[7]Kailbuchi K,Kuroda S,Amano M.Regulation of the eytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells[J].Annn Rev Biochem,1999,68 (2):459-486.

共引文献29

同被引文献39

  • 1陈一喆,赵志光,朱雪琼,吕杰强.HER2/neu蛋白在上皮性卵巢癌及其转移灶的表达及意义[J].中国全科医学,2009,12(14):1268-1271. 被引量:1
  • 2Lee RC, Feinbaum RL,Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell ,1993,75:843-854.
  • 3Lu J ,Gad G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature,2005,435:834-838.
  • 4Tsai NP, Lin YL,Wei LN. MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIPI40) mRNA and up-regulates its protein expression[J]. Bioehem J,2009,424:411-418.
  • 5Wiley A, Katsaros D, Chen H, et al. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential[J]. Cancer, 2006,107:299-308.
  • 6Murthi P, Barker G, Nowell C J, et al. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression [J]. Gynecol Oncol, 2004,92:80-88.
  • 7Adley BP, Gleason KJ, Yang XJ, et al. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma [J]. Gynecol Oncol, 2009,112:319-324.
  • 8Czekay RP, Aertgeerts K, Curriden SA, et al. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins[J]. J Cell Biol, 2003,160:781-791.
  • 9Hapke S, Kessler H, Arroyo de Prada N, et al. Integrin alpha(v)beta (3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells [J]. J Biol Chem, 2001, 276: 26340-26348.
  • 10Wang J.Y. et al. Functional significance of VEGF-a in human ovarian carcinoma: role in vasculogenic mimicry [J]. Cancer Biol Ther, 2008, 7:758-766.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部